Ticker: Wegovy and Zepbound prices fall; ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus

Published: Monday, July 7, 2025 at 8:11 pm

Wegovy, Zepbound Prices Dip, While Natural Gas Discovery Boosts Energy Hopes

In a mixed bag of economic news, prices for the widely-used obesity treatments Wegovy and Zepbound are experiencing a decline, though accessibility remains a significant hurdle for many. Simultaneously, an ExxonMobil-led consortium has announced a new natural gas discovery off the coast of Cyprus, potentially reshaping the region's energy landscape.

The cost of Wegovy and Zepbound, which are used to treat obesity, has decreased. However, the monthly cost remains around $500 for those without insurance, making them unaffordable for many patients. Even with insurance, coverage varies widely, creating challenges for patients seeking these medications. Experts like Duke University professor Matt Maciejewski, who studies obesity treatment coverage, highlight the core issue: the availability of these drugs is not the problem, but the price point and the ability of patients to sustain the cost. This situation forces physicians to seek creative solutions in patient care, but there is hope that prices may continue to fall in the future.

In the energy sector, a consortium comprising ExxonMobil and Qatar Energy International has announced a second natural gas discovery off the coast of Cyprus. This find is significant, as it strengthens the region's potential as an energy exporter. The discovery could contribute to Europe's efforts to reduce its reliance on Russian hydrocarbons by diversifying its energy sources. This development also supports the growing energy partnership between Cyprus, Greece, and Israel. The well was discovered at a depth of 6,302 feet of water, approximately 118 miles southwest of Cyprus.

BNN's Perspective:

The price fluctuations of Wegovy and Zepbound highlight the complex interplay between medical advancements, affordability, and access. While the price drop is a positive development, the persistent cost barrier underscores the need for continued efforts to ensure equitable access to essential medications. The natural gas discovery, on the other hand, presents a promising opportunity for regional energy security and diversification, which could have positive implications for Europe's energy independence.

Keywords: Wegovy, Zepbound, obesity treatment, drug prices, ExxonMobil, Qatar Energy, natural gas, Cyprus, energy discovery, energy exporter, Europe, Russian hydrocarbons, energy partnership, insurance coverage, healthcare costs

Full Story